Addex Therapeutics Ltd. (ADXN) Receivables - Net (2022 - 2024)

Addex Therapeutics' Receivables - Net history spans 3 years, with the latest figure at $17708.4 for Q4 2024.

  • For Q4 2024, Receivables - Net fell 85.77% year-over-year to $17708.4; the TTM value through Dec 2024 reached $17708.4, down 85.77%, while the annual FY2024 figure was $17633.7, 85.65% down from the prior year.
  • Receivables - Net for Q4 2024 was $17708.4 at Addex Therapeutics, down from $124416.0 in the prior quarter.
  • Across five years, Receivables - Net topped out at $432725.4 in Q4 2022 and bottomed at $17708.4 in Q4 2024.
  • The 3-year median for Receivables - Net is $124416.0 (2023), against an average of $191616.6.
  • The largest annual shift saw Receivables - Net plummeted 71.25% in 2023 before it plummeted 85.77% in 2024.
  • A 3-year view of Receivables - Net shows it stood at $432725.4 in 2022, then tumbled by 71.25% to $124416.0 in 2023, then tumbled by 85.77% to $17708.4 in 2024.
  • Per Business Quant, the three most recent readings for ADXN's Receivables - Net are $17708.4 (Q4 2024), $124416.0 (Q4 2023), and $432725.4 (Q4 2022).